126 related articles for article (PubMed ID: 28827401)
1. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Capicua drives cancer metastasis.
Okimoto RA; Breitenbuecher F; Olivas VR; Wu W; Gini B; Hofree M; Asthana S; Hrustanovic G; Flanagan J; Tulpule A; Blakely CM; Haringsma HJ; Simmons AD; Gowen K; Suh J; Miller VA; Ali S; Schuler M; Bivona TG
Nat Genet; 2017 Jan; 49(1):87-96. PubMed ID: 27869830
[TBL] [Abstract][Full Text] [Related]
3. Regulation and function of capicua in mammals.
Lee Y
Exp Mol Med; 2020 Apr; 52(4):531-537. PubMed ID: 32238859
[TBL] [Abstract][Full Text] [Related]
4. CIC is a critical regulator of neuronal differentiation.
Hwang I; Pan H; Yao J; Elemento O; Zheng H; Paik J
JCI Insight; 2020 May; 5(9):. PubMed ID: 32229723
[TBL] [Abstract][Full Text] [Related]
5. A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation.
Hori SS; Tong L; Swaminathan S; Liebersbach M; Wang J; Gambhir SS; Felsher DW
Sci Rep; 2021 Jan; 11(1):1341. PubMed ID: 33446671
[TBL] [Abstract][Full Text] [Related]
6. Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.
Tan Q; Brunetti L; Rousseaux MWC; Lu HC; Wan YW; Revelli JP; Liu Z; Goodell MA; Zoghbi HY
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1511-E1519. PubMed ID: 29382756
[TBL] [Abstract][Full Text] [Related]
7.
Yang R; Chen LH; Hansen LJ; Carpenter AB; Moure CJ; Liu H; Pirozzi CJ; Diplas BH; Waitkus MS; Greer PK; Zhu H; McLendon RE; Bigner DD; He Y; Yan H
Cancer Res; 2017 Nov; 77(22):6097-6108. PubMed ID: 28939681
[TBL] [Abstract][Full Text] [Related]
8. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
[TBL] [Abstract][Full Text] [Related]
9. A double-edged sword: The world according to Capicua in cancer.
Tanaka M; Yoshimoto T; Nakamura T
Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
[TBL] [Abstract][Full Text] [Related]
10. The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.
Weissmann S; Cloos PA; Sidoli S; Jensen ON; Pollard S; Helin K
Cancer Res; 2018 Aug; 78(15):4114-4125. PubMed ID: 29844126
[TBL] [Abstract][Full Text] [Related]
11. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
[TBL] [Abstract][Full Text] [Related]
12. Capicua deficiency induces autoimmunity and promotes follicular helper T cell differentiation via derepression of ETV5.
Park S; Lee S; Lee CG; Park GY; Hong H; Lee JS; Kim YM; Lee SB; Hwang D; Choi YS; Fryer JD; Im SH; Lee SW; Lee Y
Nat Commun; 2017 Jul; 8():16037. PubMed ID: 28855737
[TBL] [Abstract][Full Text] [Related]
13. ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
Rousseaux MWC; Tschumperlin T; Lu HC; Lackey EP; Bondar VV; Wan YW; Tan Q; Adamski CJ; Friedrich J; Twaroski K; Chen W; Tolar J; Henzler C; Sharma A; Bajić A; Lin T; Duvick L; Liu Z; Sillitoe RV; Zoghbi HY; Orr HT
Neuron; 2018 Mar; 97(6):1235-1243.e5. PubMed ID: 29526553
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic β-Cell-Derived IP-10/CXCL10 Isletokine Mediates Early Loss of Graft Function in Islet Cell Transplantation.
Yoshimatsu G; Kunnathodi F; Saravanan PB; Shahbazov R; Chang C; Darden CM; Zurawski S; Boyuk G; Kanak MA; Levy MF; Naziruddin B; Lawrence MC
Diabetes; 2017 Nov; 66(11):2857-2867. PubMed ID: 28855240
[TBL] [Abstract][Full Text] [Related]
15. Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies.
Tanaka T; Nakajima-Takagi Y; Aoyama K; Tara S; Oshima M; Saraya A; Koide S; Si S; Manabe I; Sanada M; Nakayama M; Masuko M; Sone H; Koseki H; Iwama A
J Exp Med; 2017 Oct; 214(10):2901-2913. PubMed ID: 28827447
[TBL] [Abstract][Full Text] [Related]
16. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program.
Taurozzi AJ; Beekharry R; Wantoch M; Labarthe MC; Walker HF; Seed RI; Simms M; Rodrigues G; Bradford J; van der Horst G; van der Pluijm G; Collins AT
PLoS One; 2017; 12(11):e0188228. PubMed ID: 29145505
[TBL] [Abstract][Full Text] [Related]
18. Developmental fluoride exposure influenced rat's splenic development and cell cycle via disruption of the ERK signal pathway.
Ma Y; Zhang K; Ren F; Wang J
Chemosphere; 2017 Nov; 187():173-180. PubMed ID: 28846973
[TBL] [Abstract][Full Text] [Related]
19. PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.
Qin H; Liu X; Li F; Miao L; Li T; Xu B; An X; Muth A; Thompson PR; Coonrod SA; Zhang X
Cancer Lett; 2017 Nov; 409():30-41. PubMed ID: 28844713
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
